204 related articles for article (PubMed ID: 23190898)
1. MicroRNA-26a is strongly downregulated in melanoma and induces cell death through repression of silencer of death domains (SODD).
Reuland SN; Smith SM; Bemis LT; Goldstein NB; Almeida AR; Partyka KA; Marquez VE; Zhang Q; Norris DA; Shellman YG
J Invest Dermatol; 2013 May; 133(5):1286-93. PubMed ID: 23190898
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as an emerging target for melanoma therapy.
Ryu B; Hwang S; Alani RM
J Invest Dermatol; 2013 May; 133(5):1137-9. PubMed ID: 23594536
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA miR-196a controls melanoma-associated genes by regulating HOX-C8 expression.
Mueller DW; Bosserhoff AK
Int J Cancer; 2011 Sep; 129(5):1064-74. PubMed ID: 21077158
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the Proliferation/Apoptosis Balance of Vascular Smooth Muscle Cells in Atherosclerosis by lncRNA-MEG3 via Regulation of miR-26a/Smad1 Axis.
Bai Y; Zhang Q; Su Y; Pu Z; Li K
Int Heart J; 2019 Mar; 60(2):444-450. PubMed ID: 30745534
[TBL] [Abstract][Full Text] [Related]
5. Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.
Luzi E; Marini F; Sala SC; Tognarini I; Galli G; Brandi ML
J Bone Miner Res; 2008 Feb; 23(2):287-95. PubMed ID: 18197755
[TBL] [Abstract][Full Text] [Related]
6. IL-10Rα expression is post-transcriptionally regulated by miR-15a, miR-185, and miR-211 in melanoma.
Venza I; Visalli M; Beninati C; Benfatto S; Teti D; Venza M
BMC Med Genomics; 2015 Dec; 8():81. PubMed ID: 26631117
[TBL] [Abstract][Full Text] [Related]
7. MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2.
Chen J; Xu Y; Tao L; Pan Y; Zhang K; Wang R; Chen LB; Chu X
Cell Physiol Biochem; 2017; 41(2):583-597. PubMed ID: 28214878
[TBL] [Abstract][Full Text] [Related]
8. LncRNA MIR205HG regulates melanomagenesis via the miR-299-3p/VEGFA axis.
Guo J; Gan Q; Gan C; Zhang X; Ma X; Dong M
Aging (Albany NY); 2021 Feb; 13(4):5297-5311. PubMed ID: 33535182
[TBL] [Abstract][Full Text] [Related]
9. MiR-26a inhibits proliferation and apoptosis of uveal melanoma cells via regulating p53/MDM2 pathway.
Guo Y; Tian Y
J BUON; 2020; 25(5):2476-2481. PubMed ID: 33277871
[TBL] [Abstract][Full Text] [Related]
10. miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.
Luo C; Tetteh PW; Merz PR; Dickes E; Abukiwan A; Hotz-Wagenblatt A; Holland-Cunz S; Sinnberg T; Schittek B; Schadendorf D; Diederichs S; Eichmüller SB
J Invest Dermatol; 2013 Mar; 133(3):768-775. PubMed ID: 23151846
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on
Qian H; Yang C; Yang Y
Cell Death Discov; 2017; 3():17028. PubMed ID: 28698805
[TBL] [Abstract][Full Text] [Related]
12. MiR-377 targets E2F3 and alters the NF-kB signaling pathway through MAP3K7 in malignant melanoma.
Zehavi L; Schayek H; Jacob-Hirsch J; Sidi Y; Leibowitz-Amit R; Avni D
Mol Cancer; 2015 Mar; 14():68. PubMed ID: 25889255
[TBL] [Abstract][Full Text] [Related]
13. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
[TBL] [Abstract][Full Text] [Related]
14. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
Song H; Tao Y; Ni N; Zhou X; Xiong J; Zeng X; Xu X; Qi J; Sun J
J Dermatol Sci; 2018 Sep; 91(3):317-324. PubMed ID: 30025750
[TBL] [Abstract][Full Text] [Related]
15. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
Liu R; Xie H; Luo C; Chen Z; Zhou X; Xia K; Chen X; Zhou M; Cao P; Cao K; Zhou J
J Cancer Res Clin Oncol; 2015 Jun; 141(6):993-1006. PubMed ID: 25403318
[TBL] [Abstract][Full Text] [Related]
16. Upregulation of MicroRNA-1246 Is Associated with BRAF Inhibitor Resistance in Melanoma Cells with Mutant BRAF.
Kim JH; Ahn JH; Lee M
Cancer Res Treat; 2017 Oct; 49(4):947-959. PubMed ID: 28052651
[TBL] [Abstract][Full Text] [Related]
17. Tumor-suppressive miR-26a and miR-26b inhibit cell aggressiveness by regulating FUT4 in colorectal cancer.
Li Y; Sun Z; Liu B; Shan Y; Zhao L; Jia L
Cell Death Dis; 2017 Jun; 8(6):e2892. PubMed ID: 28640257
[TBL] [Abstract][Full Text] [Related]
18. Regulation of pulmonary surfactant synthesis in fetal rat type II alveolar epithelial cells by microRNA-26a.
Zhang XQ; Zhang P; Yang Y; Qiu J; Kan Q; Liang HL; Zhou XY; Zhou XG
Pediatr Pulmonol; 2014 Sep; 49(9):863-72. PubMed ID: 24395810
[TBL] [Abstract][Full Text] [Related]
19. A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.
Liu J; Li X; Wang M; Xiao G; Yang G; Wang H; Li Y; Sun X; Qin S; Du N; Ren H; Pang Y
Int J Oncol; 2018 Oct; 53(4):1601-1612. PubMed ID: 30066905
[TBL] [Abstract][Full Text] [Related]
20. The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.
Cabello P; Pineda B; Tormo E; Lluch A; Eroles P
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27517917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
